Multi-omic analysis of stroke recurrence in African Americans from the Vitamin Intervention for Stroke Prevention (VISP) clinical trial.
African Americans endure a nearly two-fold greater risk of suffering a stroke and are 2-3 times more likely to die from stroke compared to those of European ancestry. African Americans also have a greater risk of recurrent stroke and vascular events, which are deadlier and more disabling than incide...
Main Authors: | Nicole M Davis Armstrong, Kelsey J Spragley, Wei-Min Chen, Fang-Chi Hsu, Michael S Brewer, Patrick J Horn, Stephen R Williams, Michèle M Sale, Bradford B Worrall, Keith L Keene |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0247257 |
Similar Items
-
DNA methylation analyses identify an intronic ZDHHC6 locus associated with time to recurrent stroke in the Vitamin Intervention for Stroke Prevention (VISP) clinical trial.
by: Nicole M Davis Armstrong, et al.
Published: (2021-01-01) -
Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial
by: Nicole M. Davis Armstrong, et al.
Published: (2018-09-01) -
Genetic associations with plasma B12, B6, and folate levels in an ischemic stroke population from the Vitamin Intervention for Stroke Prevention (VISP) trial
by: Keith L Keene, et al.
Published: (2014-08-01) -
Association of Optimal Combination Drug Treatment with Obesity Status among Recent Ischemic Stroke Patients: Results of the Vitamin Intervention for Stroke Prevention (VISP) Trial
by: Jong-Ho Park, et al.
Published: (2017-05-01) -
Risk of recurrent stroke for Asian stroke patients treated with non-vitamin K antagonist oral anticoagulant and warfarin
by: Sheng-Feng Lin, et al.
Published: (2020-11-01)